Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.

Abstract:

:The purpose of this study was to clarify the mechanism of IFN-α resistance in RCC. The effects of IFN-α on induction of apoptosis and cell-cycle arrest were analyzed by flow cytometric analysis. Jak-Stat pathway components induced by IFN-α was evaluated using Western blotting. The results suggested that IFN-α caused growth inhibition of RCC cell lines via arrest in the G1 phase without inducing apoptosis. The resistance of RCC to IFN-α was associated with the low expression of Stat1. This study indicated that the Jak-Stat pathway should be considered a primary target for improving the response of RCC to IFN-α treatment.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Shang D,Yang P,Liu Y,Song J,Zhang F,Tian Y

doi

10.3109/07357907.2011.568566

subject

Has Abstract

pub_date

2011-06-01 00:00:00

pages

347-52

issue

5

eissn

0735-7907

issn

1532-4192

journal_volume

29

pub_type

杂志文章
  • The response of the microvascular system to radiation: a review.

    abstract::The microvasculature is a ubiquitous organ system having a major role in the pathogenesis of radiation damage to normal tissues. Although the kinetics of radiation damage to endothelial cells is similar to other tissues (as reflected by Do and Dq) the late effect is a manifestation of injury, not only to the endotheli...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908909039849

    authors: Baker DG,Krochak RJ

    更新日期:1989-01-01 00:00:00

  • Reversible deficiency of serum high density lipoproteins in Hodgkin's disease.

    abstract::An elderly woman with Hodgkin's disease and hepatic involvement but without cholestasis presented with markedly depressed levels of serum esterified cholesterol and high density lipoproteins (HDL). Within five days of her first cycle of chemotherapy her serum HDL-cholesterol rose from 8-10 mg/dl to 88 mg/dl, and level...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609017510

    authors: Herbert PN,Friedland ML

    更新日期:1986-01-01 00:00:00

  • Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field.

    abstract::Metronomic chemotherapy refers to the chronic, equally spaced, delivery of low doses of chemotherapeutic drugs, without extended interruptions. Previously, we developed two combined metronomic schemes for the treatment of murine mammary tumors. The aim of this study was to compare their effects on tumor and metastasis...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.877480

    authors: Rico MJ,Perroud HA,Mainetti LE,Rozados VR,Scharovsky OG

    更新日期:2014-03-01 00:00:00

  • The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs.

    abstract::Hepatitis B virus X protein (HBx) promotes hepatocellular carcinoma (HCC) invasion and metastasis by a poorly understood mechanism. This study investigated the role of NF-kappa B in HBx-mediated upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In a stably expressing HBx c...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903405959

    authors: Liu LP,Liang HF,Chen XP,Zhang WG,Yang SL,Xu T,Ren L

    更新日期:2010-06-01 00:00:00

  • Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.

    abstract::Acute promyelocytic leukemia (APL) is characterized by specific t(15;17), distinct morphologic picture, and clinical coagulopathy that contribute to the morbidity and mortality of the disease. This study aims to investigate the effects of antitelomerase compound BIBR1532 on APL cells (NB4). BIBR 1532 exerts a direct s...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.629378

    authors: Bashash D,Ghaffari SH,Zaker F,Hezave K,Kazerani M,Ghavamzadeh A,Alimoghaddam K,Mosavi SA,Gharehbaghian A,Vossough P

    更新日期:2012-01-01 00:00:00

  • Nerve growth factor receptor immunoreactivity in breast cancer patients.

    abstract::Nerve growth factor receptor (NGF-R) has been shown to have antiproliferative, differentiative, or apoptotic effects on some types of tumor cells, whereas in others it may have mitogenic activity. The immunohistochemical distribution of NGF-R was analyzed in a series of tissue samples from breast cancer patients and i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100106144

    authors: Aragona M,Panetta S,Silipigni AM,Romeo DL,Pastura G,Mesiti M,Cascinu S,La Torre F

    更新日期:2001-01-01 00:00:00

  • 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.

    abstract::A phase II trial of 5-fluorouracil (5-FU) [250-450 mg/m2/day x 5 days as an intravenous (IV) bolus] combined with calcium leucovorin (500 mg/m2/day x 5 1/2 days by continuous IV infusion) administered on a 28-day schedule was performed in 15 patients with advanced hepatocellular carcinoma. The median age was 58 years;...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509024907

    authors: Tetef M,Doroshow J,Akman S,Coluzzi P,Leong L,Margolin K,Morgan RJ Jr,Raschko J,Shibata S,Somlo G

    更新日期:1995-01-01 00:00:00

  • Emotional Response of US Breast Cancer Survivors during the COVID-19 Pandemic.

    abstract::In a sample of 633 US adult breast cancer survivors, we examined health-related worry as a function vulnerability as influenced by communication, trust, and planning with their cancer care team during the COVID-19 pandemic. We found significant positive correlations between communication and trust, communication and p...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1841220

    authors: Papautsky EL,Hamlish T

    更新日期:2021-01-01 00:00:00

  • Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.

    abstract::The purpose of this study was to assess the usefulness of thallium-201 (Tl-201) single-photon emission-computed tomography (SPECT) scintimammography to differentiate benign from malignant breast masses in 32 female Taiwanese patients with indeterminate mammographic probability of malignancy because of mammographically...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120025089

    authors: Chiou JF,Lin MC,Chen DR,Jim YF,Kao CH

    更新日期:2003-01-01 00:00:00

  • Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.

    abstract::Tumor-infiltrating leukocytes and other immunohistochemical parameters were evaluated in pretherapeutic biopsies and resection specimens in 73 patients undergoing neoadjuvant chemotherapy with doxorubicin and paclitaxel. Ten patients with pathological complete response had significantly higher p53 expression, CD3(+) l...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802098165

    authors: Hornychova H,Melichar B,Tomsova M,Mergancova J,Urminska H,Ryska A

    更新日期:2008-12-01 00:00:00

  • Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

    abstract::Placement of carmustine-impregnated wafers has become a common practice after surgical resection of malignant gliomas. Bevacizumab is used as a second-line agent for the treatment of malignant gliomas and is sometimes used in patients who have had recent wafer implantation. We describe two cases of fatal cerebrospinal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2010.483499

    authors: Nagaiah G,Almubarak M,Khan M,Altaha R

    更新日期:2010-12-01 00:00:00

  • Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma.

    abstract::Radioimmunotherapy (RIT) is a promising new treatment option for patients with relapsed/refractory non-Hodgkin's lymphoma. Clinical trials have demonstrated that both iodine-131 (131I) and yttrium-90 (90Y) are suitable radionuclides for RIT. Iodine-131 and 90Y differ markedly in their physical properties including hal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120016421

    authors: Leonard JP,Siegel JA,Goldsmith SJ

    更新日期:2003-04-01 00:00:00

  • Managing patients and families at the ending of life: hospice assumptions, structures, and practice in response to staff stress.

    abstract::Hospice programs do not identify burnout as a significant staff problem, even though there are many significant stressors for staff members doing hospice work. Hospices offer support in a wide variety of ways and settings through their human resources management. All this support is predicated on the assumption that t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709039724

    authors: Brenner PR

    更新日期:1997-01-01 00:00:00

  • Peroxiredoxin overexpression in MCF-7 breast cancer cells and regulation by cell proliferation and oxidative stress.

    abstract::Peroxiredoxins are thiol-specific antioxidant proteins that protect cells from ROS-induced cell death and are elevated in several cancers. We found that five of the six mammalian peroxiredoxins are overexpressed in MCF-7 breast cancer cells at the mRNA and protein levels, compared to noncancerous MCF-10A cells. Inhibi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.802798

    authors: Tehan L,Taparra K,Phelan S

    更新日期:2013-07-01 00:00:00

  • Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.

    abstract::Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied abou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1582060

    authors: Luwor R,Morokoff AP,Amiridis S,D'Abaco G,Paradiso L,Stylli SS,Nguyen HPT,Tarleton M,Young KA,O'Brien TJ,Robinson PJ,Chircop M,McCluskey A,Jones NC

    更新日期:2019-01-01 00:00:00

  • Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

    abstract::Serum C-reactive protein (CRP), a sensitive marker of systemic inflammation, has been reported to be associated with the risk of a number of cancers including breast cancer. However, the results are inconsistent. To investigate the association between serum CRP levels and early breast cancer, we conducted a hospital-b...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.789898

    authors: Hong T,Liu A,Cai D,Zhang Y,Hua D,Hang X,Wu X

    更新日期:2013-05-01 00:00:00

  • Prospective study on combination of electrical impedance scanning and ultrasound in estimating risk of development of breast cancer in young women.

    abstract::Based on cost-effective ratio, there has not yet been imaging methods suitable for breast cancer screening in young women. The aim of this study was to evaluate the sensitivity and specificity of the combination of electrical impedance scanning (EIS) and ultrasound in identifying breast cancer for young women, to calc...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357900802203658

    authors: Wang T,Wang K,Yao Q,Chen JH,Ling R,Zhang JL,Dong XZ,Fu F,Dou KF,Wang L

    更新日期:2010-03-01 00:00:00

  • A phase I study of gemcitabine and docetaxel for advanced stage solid tumors.

    abstract:BACKGROUND:We conducted a phase I study to determine the maximum tolerated dose of docetaxel in combination with gemcitabine for patients with refractory solid tumors. METHODS:From January 1998 to November 1999, we treated 28 patients on a phase I protocol with gemcitabine given at a constant dose of 800 mg/m2 i.v. ov...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120018225

    authors: Poole ME,Bernard SA,Churchel MA,Weissler MC,Calvo B,Cance W,Ollila D,Koruda M,Behrns K,Detterbeck FC

    更新日期:2003-06-01 00:00:00

  • Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients.

    abstract::Oncologists deal almost exclusively with patients with serious and life-threatening diseases, many who are terminally ill. While hospice care remains an ideal model of care for cancer patients with life-ending disease, many obstacles are present in the clinical setting that either impede or prevent the otherwise appro...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120027587

    authors: Daugherty CK

    更新日期:2004-01-01 00:00:00

  • Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?

    abstract::For women with hormone receptor-positive disease, the third-generation aromatase inhibitors (AIs), anastrozole, letrozole, and exemestane, are more effective than tamoxifen in improving disease-free survival (DFS) when used initially or as adjuvant therapy following two to three years of tamoxifen or after tamoxifen h...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701781812

    authors: Tang SC

    更新日期:2008-06-01 00:00:00

  • Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.

    abstract::A case control study was undertaken to investigate the association of polymorphisms in cytochrome P4501A1 (CYP1A1) with squamous cell carcinoma of head and neck (HNSCC) in North Indian population. The variant genotypes of CYP1A1*2A and CYP1A1*2C were found to be overrepresented in cases when compared to controls. The ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900902849657

    authors: Singh AP,Shah PP,Ruwali M,Mathur N,Pant MC,Parmar D

    更新日期:2009-10-01 00:00:00

  • DNA biomarkers antecede semiquantitative anthracycline cardiomyopathy.

    abstract::Adriamycin (ADM, or doxorubicin hydrochloride) is an effective antineoplastic agent whose use is restricted by its well-described, dose-dependent cardiotoxicity. This study measures ADM DNA adduct formation by 32P-radiolabeling DNA, enzymatically digesting radiolabeled DNA, separating the formed adducts on two-dimensi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120016404

    authors: Hahm S,Dresner HS,Podwall D,Golden M,Winiarsky R,Moosikasuwan M,Cajigas A,Steinberg JJ

    更新日期:2003-01-01 00:00:00

  • Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.

    abstract:OBJECTIVES:To evaluate the efficacy and toxicity of the combination of vinorelbine and interleukin (IL)-2 in patients with metastatic melanoma as second-line chemotherapy. PATIENTS AND METHODS:Twenty-two patients with histologically confirmed stage IV melanoma previously treated with temozolomide-based chemotherapy--o...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1081/cnv-200039630

    authors: Gogas H,Bafaloukos D,Aravantinos G,Fountzilas G,Tsoutsos D,Panagiotou P,Frangia K,Kalofonos HP,Briasoulis E,Castana O,Polyzos A,Pectasides D,Ioannovich J,Hellenic Cooperative Oncology Group.

    更新日期:2004-01-01 00:00:00

  • Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer.

    abstract::Fulvestrant (Faslodex) is a new type of estrogen receptor (ER) antagonist that binds, blocks, and degrades the ER, leading to reduced expression of the progesterone receptor (PgR). Unlike the selective ER modulator tamoxifen, fulvestrant is devoid of any known agonist activity. Fulvestrant has a steroidal structure th...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-50480

    authors: Bundred N

    更新日期:2005-01-01 00:00:00

  • Mitochondrial DNA alterations in cancer.

    abstract::A number of studies have demonstrated the presence of mitochondrial DNA (mtDNA) mutations in cancer cells. In this article, we review mitochondrial genomic aberrations reported in solid tumors of the breast, colon, stomach, liver, kidney, bladder, head/neck, and lung. The tantalizing association of tumors with mtDNA m...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120002155

    authors: Copeland WC,Wachsman JT,Johnson FM,Penta JS

    更新日期:2002-01-01 00:00:00

  • A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

    abstract::Despite increasing evidence of benefit from adjuvant chemotherapy, older women with breast cancer are commonly given less aggressive treatment than younger patients. Conflicting prior data regarding age-related toxicity prompted this prospective study. Forty-four women (aged 35-79 years) with early-stage breast cancer...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900009012191

    authors: Dees EC,O'Reilly S,Goodman SN,Sartorius S,Levine MA,Jones RJ,Grochow LB,Donehower RC,Fetting JH

    更新日期:2000-01-01 00:00:00

  • Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

    abstract::Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycli...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909309024827

    authors: Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

    更新日期:1993-01-01 00:00:00

  • Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC).

    abstract::The aim was to determine whether promoter methylation of BRCA1, MGMT, MLH1, RASSF1A, and p16 genes could predict response to platinum-based chemotherapy. Thirty-five subjects with epithelial ovarian cancer (EOC) treated by platinum-based chemotherapy were recruited. Methylation-specific polymerase chain reaction was c...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900902849699

    authors: Chaudhry P,Srinivasan R,Patel FD

    更新日期:2009-10-01 00:00:00

  • Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.

    abstract::The transforming growth factor beta 1 (TGF-beta1) is a multifunctional cytokine with several regulatory activities in tumor cells affecting growth, differentiation, and function. Alterations in gene expression, secretion, and regulation of TGF-beta1 may lead to a favorable environment for tumor development by angiogen...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701600921

    authors: Faria PC,Saba K,Neves AF,Cordeiro ER,Marangoni K,Freitas DG,Goulart LR

    更新日期:2007-12-01 00:00:00

  • A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

    abstract::This study compared the antiemetic efficacy and safety of two different intravenous (i.v.) dolasetron dosing regimens in patients receiving their first course of high-dose (> or = 80 mg/m2) cisplatin. Of 30 patients enrolled, 14 received a single i.v. dolasetron dose (0.6 mg/kg) before cisplatin and 16 received a mult...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3109/07357909709039730

    authors: Kasimis BS,Tapazoglou E,Schulman P,Stewart WH,Hahne WF,Cramer MB

    更新日期:1997-01-01 00:00:00